Menu
A group of executives with track-proven record of success in the medical device industry and expertise on Commercialisation, Operations, Clinical Investigation and Research & Development.
Alain has more than 20 years of experience in development and manufacturing of active implantable devices. As first employee of Endoart SA, he was playing a key role in all aspects of project and technology management. He has a thorough knowledge of EU and US requirements relative to the development and production of active implantable devices.
After the acquisition of Endoart SA by Allergan Inc., he was leading a multidisciplinary team of 28 people involved in the development and manufacturing of active implantable devices. Alain obtained his MS in Microengineering from EPFL, and his Postgraduate Degree in Biomedical Engineering from EPFL, Lausanne University and Geneva University, Switzerland.
André completed his doctoral thesis on the in vivo application of neurological implants formed Alevaʼs core technology. He gained product development experience at MIT Artificial Intelligence Laboratory, Zyvex Corporation (TX, USA) and Bosch Research (Silicon Valley, USA).
He holds over 10 international patent families on neuromodulation and micro-assembly of medical devices. André obtained his BS in Engineering Physics from the University of Toronto, MS in Management Science from Stanford University, and PhD in Biomedical Engineering from the EPFL, Switzerland.
Alexandre joined Aleva in June 2021 to support the Company in the transition towards commercialization. Prior to Aleva, Alexandre was CFO / VP of Finance and Administration at Genkyotex, a Swiss biotech company listed on Euronext Paris and Brussels. Alexandre played a key role in the Reverse Take Over (RTO) process through which Genkyotex became public in 2017 and in the strategic combination with Calliditas Therapeutics in 2020/2021.
Alexandre has more than 20 years of industry experience mainly in the Pharma/Biotech/Medtech sector in Switzerland with Genkyotex, Alexion and Novartis. He started his career in 2000 as a financial auditor working for KPMG in Paris.
Alexandre brings a wealth of experience and expertise in the development of high-end medical devices across various domains, with a remarkable 15-year track record. His strong leadership skills have been evident in his successful management of R&D and technical teams for the past 5 years. Alexandre holds a BS in Micro and Nanotechnologies from the esteemed University of Neûchatel, as well as an MS in Microsystems Engineering from the prestigious EPFL.
Throughout his career, Alexandre has played a pivotal role in the product development landscape. At Myopowers, he played a key part in the development of an artificial urinary sphincter, showcasing his innovative approach. Later, at Mitralflex, Alexandre led the team in creating a postimplant adjustable mitral ring, demonstrating his ability to drive meaningful advancements. Prior to joining Aleva, he collaborated with the CHUV on an external ventricular assist device project that harnessed artificial muscle technology, further expanding his expertise.
Matthias brings more than twenty years of experience as an executive or advisor for leading medical device companies in the neurological, trauma and orthopedic categories to Aleva.
Prior to joining Aleva in January 2020, Matthias held leadership and consultancy roles at Nevro, aap Bioimplants, Benvenue Medical, DePuy Spine and Kyphon (acquired by Medtronic), focussed on clinical and product to market implementation in addition to his clinical expertise as an intensive care and emergency physician.
Alain has extensive experience in medical devices, first with Haemonetics Corporation (automated blood separation), then with Medtronic Europe (pacemakers and heart valves), and most recently as a consultant in Product Management, Market Analysis and Clinical Management.
He has led clinical validation of new products, market research, and product launch in Europe. Alain obtained his MS in Electrical Engineering from EPFL and followed the PED management program at IMD, Switzerland.
With a large team of specialised people with expertise in DBS technology applied to Neurological and Psychiatric diseases, Aleva is well suited to be a significant player in the European DBS market.
Contact us to receive a visit from the sales specialists closest to you.